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First described in the Indian rhinoceros in the year 1862 [1], the 
parathyroid glands are intimately related to the thyroid gland. Normal 
parathyroid function is integral to the calcium homeostasis in the body. 
However, thyroid surgery in general and total thyroidectomy in particular 
is associated with a significant risk of parathyroid injury, post-operative 
hypoparathyroidism and hypocalcemia. While acute hypocalcemia has 
various dramatic clinical features ranging from paresthesias to seizures 
and even death, chronic hypocalcemia can result in crippling 
complications including heart failure and cardiomyopathy.  
Generally, post-operative hypocalcemia and hypo-parathyroidism 
are transient phenomena which resolve spontaneously over time. 
Definitive hypo-parathyroidism and chronic hypocalcemia occur as a 
result of irreversible loss of function of the parathyroids, invariably due 
to inadvertent removal or ischemic necrosis of the parathyroid glands. So, 
definitive hypo-parathyroidism is a complication that can be prevented 
with better intra-operative care.  
The best approach to prevent definitive hypo-parathyroidism is to 
identify the parathyroids and their blood supply during surgery. Should 
the gland be inadvertently removed or rendered ischemic due to vascular 
compromise, it can be auto-transplanted to a heterotopic site. The 
parathyroid tissue has certain unique properties, by virtue of which auto-
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transplantation is a viable option in order to prevent chronic 
hypoparathyroidism and hypocalcemia. 
However, the success of this procedure depends upon whether the 
transplanted tissue is viable and functional. Functionality of the graft can 
be assessed by confirmation of parathormone (PTH) secretion. This can 
be determined by estimating serum level of PTH in the effluent from the 
graft in the draining veins, and by comparison with serum level of PTH in 
the peripheral circulation.      
This study was conducted in the Department of Endocrine Surgery, 
Madras Medical College with an objective to assess the functionality of 
the auto-transplanted gland during thyroidectomy and parathyroid auto-
transplantation.  
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2.1 HYPOCALCEMIA AND HYPO-PARATHYROIDISM 
 
         The primary objective of this study was to assess the functional 
status of the auto-transplanted parathyroid gland during total 
thyroidectomy. However, the focus of this study is post-operative hypo-
parathyroidism and hypocalcemia after thyroid surgery. Attempts at 
resolution are helped no end by a thorough understanding of the problem, 
including epidemiology, causative factors, clinical presentation and 
management of post-operative hypocalcemia and hypo-parathyroidism. 
 
2.1.1 Epidemiology 
While clinically significant hypocalcemia following thyroid 
surgery is due to hypoparathyroidism [2-5], it is generally temporary and 
limited to the first few weeks after surgery. Various researchers have 
reported that the incidence of transient hypocalcemia following thyroid 
surgery is 2% - 51% [6-10]. Adverse events tend to be under reported in 
the literature and so, the true incidence of permanent hypoparathyroidism 
is difficult to ascertain. However, the incidence of permanent post-
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operative hypoparathyroidism complicating thyroid surgery ranges 
between 0% and 43% [4, 11-13]. 
It is evident from world literature that transient hypocalcemia is 
seen so frequently after total thyroidectomy that it is now considered a 
sequel of total thyroidectomy and is no longer considered a complication. 
While symptomatic hypoparathyroidism can be dramatic in 
presentation, it is clinically occult in the majority of patients with only 
biochemical evidence of hypocalcemia and sub-normal S. PTH levels.  
 
2.1.2 Etiology: factors that increase the risk of post-operative 
hypocalcemia 
The main cause of hypoparathyroidism following total 
thyroidectomy is mechanical parathyroid injury or inadvertent 
parathyroidectomy.  
Injudicious use of electro-cautery, especially uni-polar diathermy, 
will increase the risk of parathyroid injury. Although they may be 
mechanically intact, the risk for thermal injury and coagulation is 
increased. So, extreme care is advocated with regards to uni-polar 
diathermy, once the investing layer of cervical fascia is opened.  
Bleeding will muddle the field of surgery and as a result, accurate 
identification of the vital structures including parathyroid glands is 
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hindered. So, perfect hemostasis during surgery, especially in the 
proximity of parathyroid glands, is vital and is best achieved by 
meticulous dissection and bipolar diathermy, if available.  
Magnification of the field with the help of loupes is one method of 
improving the identification of the glands and their blood supply [14]. 
However, it takes time to adjust oneself to the usage of loupes during 
surgery. 
In spite of the best and supposedly successful efforts to preserve 
the anatomical integrity of the parathyroids, hypoparathyroidism can and 
does occur. A mechanically intact parathyroid gland may be rendered 
ischemic due to vascular compromise. Although the gland itself and its 
blood supply may be structurally intact, hypoparathyroidism may occur 
due to spasm of the vessels. 
 Research has revealed that patients with normal S. iPTH levels (intact 
PTH in circulation) at the end of surgery can develop subnormal levels 
after surgery [15].  
In a study by Vidyasagar, et al. [15], the intra-operative and post-
operative iPTH levels were estimated and correlated with the number of 
parathyroid glands which were devascularized or removed during total 
thyroidectomy. All those patients who had two or more viable and 
functional glands had normal levels of iPTH, with no significant 
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difference between the intra-operative iPTH levels among them. In those 
patients with three devascularized glands, the iPTH levels were 
subnormal, while iPTH was undetectable after devascularization of four 
parathyroids. In a similar study, Rafferty, et al. [16] correlated post-op 
hypocalcemia with number of glands found in the specimen after 
thyroidectomy. The finding of 3 or more parathyroid glands in the 
specimen correlated with an incidence of 100% for post-operative 
hypocalcemia, while the incidence rate was 18% or less when two or 
fewer parathyroid glands were found on the specimen.  
So it follows that at least two viable, functional parathyroid glands 
are necessary for maintenance of normocalcemia and euparathyroidism 
post-operatively.  
Histopathological examination of the operated specimen confirms 
inadvertent parathyroidectomy. When evaluated so, the incidence of 
unintentional parathyroidectomy ranges from 9% to 19% in different 
series [17, 18]. Inadvertent parathyroidectomy during thyroid surgery is 
another factor that will influence post-operative hypoparathyroidism.  
Recurrent goitre and revision thyroidectomy is also associated with 
an increased risk of transient and permanent postoperative 
hypoparathyroidism [17, 21]. 
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Risk of post-operative hypoparathyroidism and hypocalcemia is 
also increased in thyroid carcinoma and the procedure of lymph node 
dissection that may be necessitated [2, 21]. Moley and de Benedetti [22] 
reported that if adequate central node dissection performed, then it is 
extremely difficult to preserve adequately perfused parathyroid glands in 
situ, especially the inferior parathyroids. 
In addition to anatomical and surgical reasons for postoperative 
hypoparathyroidism and hypocalcemia, there are other factors which 
influence the development of post-operative hypoparathyroidism and 
hypocalcemia. 
Graves’ disease [17] and thyrotoxicosis in general [19], lead to an 
increased risk of transient and permanent postoperative 
hypoparathyroidism. The higher incidence of transient hypocalcemia in 
thyrotoxic patients is related to the increased skeletal avidity for calcium 
associated with this pathology [4]. 
Indeed, there appears to be a correlation between temporary postoperative 
hypocalcemia and free thyroxine levels [20]. 
Apart from thyroid surgery, when the parathyroid glands are 
obviously at risk of injury and necrosis, hypocalcemia has been shown to 
occur after other surgeries such as herniorrhaphy as well [4]. This decline 
in serum calcium was seen to occur within 24 hours of surgery. The 
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change in the levels of calcium and other electrolytes in circulation was 
found to be very similar to that seen after thyroidectomy. 
In the post-operative setting, macrodilution of the intravascular 
fluid compartment may occur due to excessive replacement of 
intravenous crystalloids. This may result in hypocalcemia [23]. General 
anesthesia has been reported as a cause for post-operative hypocalcemia 
[23].  
Calcium homeostasis is influenced by another similar divalent 
cation, Magnesium. Hypomagnesemia renders the parathyroids less 
sensitive to falling calcium levels, thus suppressing PTH secretion. In 
addition, the PTH receptors are also rendered less responsive to PTH. 
Indeed, hypo-magnesemia has been reported to be an important cause of 
post-operative hypocalcemia [23]. However, this is difficult to detect and 
should be suspected in cases of hypocalcemia refractory to intravenous 
Calcium replacement. 
Extensive surgery entails prolonged periods of exposure of the 
field to low ambient temperatures, causing hypothermia, which may 
result in hypocalcemia. Hypothermia in the field due to air-conditioning 
in the operating theatre could be a factor and this can be addressed by 
periodic irrigations with warm saline. This was evident in a study by 
Testini, et al. [24], when it was found that the risk of post-operative 
 9 
 
hypocalcemia was low when the operative field was irrigated with 
lukewarm saline from time to time.  
So, it is evident that there is a multitude of factors which influence 
the level of Calcium in the circulation in the post-operative period. 
 
2.1.3 Hypocalcemia: Definition and Clinical presentation 
S. Calcium is measured both in mmol/l and mg/dl. 1 mmol/l is 
equivalent to 0.25 mg/dl. Eucalcemia or normocalcemia refers to S. 
Calcium levels between 8.5 and 10.5 mg/dl. Hypocalcemic symptoms 
are uncommon unless the level of S. Calcium is less than 8.0 mg/dl 
[25, 26]. 
When S. Calcium levels return to normal within 6 months after 
surgery, it is transient or temporary hypocalcemia [25, 27]. If the patient 
presents with hypocalcemia within 24 hours of surgery, it is termed 
Immediate Hypocalcemia [25, 27]. Delayed hypocalcemia refers to 
presentation after the first 24 hours post-operatively [25, 27]. Permanent 
or definitive post-operative hypocalcemia refers to hypocalcemia that 
persists for 6 months post-operatively or longer [25, 27].  
Hypocalcemia commonly presents on the 2
nd
 or 3
rd
 post-operative 
day. The various clinical features of hypocalcemia depending on the 
organ system affected are listed overleaf in Box 1 [27]. 
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BOX 1: CLINICAL FEATURES OF ACUTE HYPOCALCEMIA 
Neuromuscular irritability: 
Symptoms 
Paresthesias - acral and facial tingling and numbness  
Muscle weakness  
Muscle cramps, felt in the limbs predominantly  
Tetany  
Laryngeal spasm - Stridor  
Bronchospasm 
       Seizures – focal, petit mal or grand mal 
 Signs 
Trousseau’s sign: Flexion and adduction of carpal and 
metacarpo-phalangeal joints induced by 
supra-systolic occlusion of the brachial 
artery. 
Chvostek’s sign :  Twitch of the angle of mouth, the 
nasolabial fold, nasal ala or half of the 
face including forehead on flicking the 
angle of the lower jaw 
Neurological features: 
 Symptoms 
   Personality disturbances, Anxiety and Irritability 
   Choreo-athetosis and Dystonic spasms 
   Confusion, Disorientation, Psychosis  
 Signs 
Non-specific EEG changes 
   Increased intracranial pressure - Papilledema 
 
Cardiac involvement: 
 Qt prolongation on ECG 
 Cardiac failure  
 
Smooth muscle involvement: 
 Dysphagia 
 Dyspnea 
 Biliary colic 
 Abdominal pain 
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Chvostek’s sign and Trousseau’s sign deserve a special mention 
because of the fact that they are the measures most often employed for 
objective clinical assessment of calcemic status.  
Chvostek’s sign was first described in 1876 by Frantisek Chvostek, an 
Austrian surgeon. Elicited by flicking the skin over the angle of the 
mandible and looking for twitches over the face, it refers to twitching of 
the muscles of the face as a result of direct mechanical stimulation of the 
motor fibers in the facial nerve. If twitches are seen, then the sign is 
positive. This sign has been graded on the basis of how widespread the 
twitches are over the face.  
Chvostek’s sign has been graded according to severity [28]. Chvostek 
I, the severest and most acute degree of positivity, refers to twitches seen 
over the whole of the side of the face, including the forehead, the 
nasolabial fold, nasal ala and the angle of the mouth, which can be 
elicited by light stroking of the finger over the angle of the mouth. 
Chvostek II refers to twitches seen over the ipsilateral naso-labial fold 
and the nasal ala. Chvostek III, the mildest degree of positivity, refers to 
twitch seen over the ipsilateral angle of the mouth alone. 
However, the grade of positivity does not correlate with the degree of 
severity of hypocalcemia. Nor is Chvostek’s sign always positive in 
patients with hypocalcemia. In upto 29% of cases of bio-chemically 
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confirmed post-operative hypocalcemia, Chvostek’s sign is falsely 
negative. In addition, conditions like rickets, myxedema, alkalosis and 
some acute infections like diphtheria, pertussis and measles include some 
of the causes of false positivity of Chvostek’s sign. Thus, with a false-
positivity of 25% and a similarly high false negativity rate, a positive 
Chvostek’s sign is not a very accurate indicator of hypocalcemia.   
Trousseau’s sign is elicited by occlusion of the brachial artery with 
supra-systolic pressure applied by means of the cuff of a 
sphygmomanometer. If the hand assumes the ‘accoucher’s’ position 
(flexion and adduction of the carpal, carpo-metacarpal and the 
metacarpo-phalangeal joints, along with various degrees of flexion of the 
inter-phalangeal joints) on vaso-occlusion, then the test is positive. 
However, this is of significance if these changes are seen within two 
minutes, or 120 seconds, of vaso-occlusion. If the occlusion is maintained 
longer, the changes are seen even in healthy subjects. A positive 
Trousseau’s response can be graded on the basis of whether changes are 
seen within 30 seconds, between 30 and 60 seconds or between 60 and 
120 seconds after vaso-occlusion.   
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2.1.4 Management of post-operative hypocalcemia 
 There are two aspects of management of post-operative 
hypocalcemia including prevention and treatment of the condition, once it 
occurs.  
Prediction of impending hypocalcemia is vital in prevention of this 
eventuality. Various studies have been conducted to establish indicators 
for prediction of post-operative hypocalcemia. If hypocalcemia can be 
predicted before clinical presentation, prophylaxis can be started so that 
clinically overt hypocalcemia is forestalled.  
Development of hypocalcemia and hypoparathyroidism can be 
predicted within 24 hours of surgery by estimating S. Calcium and S. 
PTH levels on the first post-operative day. When calcium levels were 
plotted as function of time [29], the slope of change of total S. Calcium 
between 8
th
 & 14
th
 post op hour in hypocalcemic patients was 
significantly steeper than that in normocalcemics patients. Serial 
estimations of S. Calcium were performed on an hourly basis. The 
Calcium slope was calculated as shown below: 
Calcium slope = Calcium 2 - calcium 1/ Calcium 1 (Time 2 – Time 1) 
 
Calcium 2 refers to the sample taken later, at Time 2 after operation, and 
Calcium 1 refers to the sample taken earlier, at Time 1 after operation.  
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In the post-operative period, calcium levels start to fall after 24 hours of 
surgery, reaching a nadir 72 hours after surgery, after which the levels 
rise again. So, estimation of S. Calcium on the first, second and the third 
post-operative day will enable the detection of biochemical 
hypocalcemia. 
Treatment involves a spectrum of measures ranging from bolus 
intravenous calcium injection and intravenous infusion through oral 
calcium and vitamin D supplementation to oral calcium supplementation 
alone. Grading of the severity of hypocalcemia affords optimization of 
therapy. Hypocalcemia can be graded on the basis of clinical features, or 
more exactly, on the basis of S. Calcium. 
Severity of hypo-calcemia is graded on the basis of S. Calcium 
levels in the circulation. Eucalcemia refers to S. Calcium levels between 
8.5 mg/dl and 10.0 mg/dl. Mild hypocalcemia refers to S. Calcium levels 
between 8.0 mg/dl and 8.4 mg/dl. Moderate hypocalcemia refers to S. 
Calcium levels between 7.5 mg/dl and 7.9 mg/dl. Severe hypocalcemia 
refers to S. Calcium levels below 7.0 mg/dl. Life-threatening hypo-
calcemia refers to S. Calcium levels below 7.0 mg/dl.   
While oral calcium supplementation is adequate for mild 
hypocalcemia, moderate or severe hypocalcemia, characterized by S. 
Calcium levels below 8.0 mg/dl, necessitates intravenous calcium 
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replacement.   No correlation has been established between severity of 
symptoms and the degree of hypocalcemia.  
However, Trousseau’s sign correlated with severe hypocalcemia. 
Those patients with positive Trousseau’s sign require intravenous 
replacement, in the form of a bolus followed by intravenous infusions. 
Continuous monitoring of pulse and ECG and periodic monitoring of S. 
Calcium levels is essential during intravenous calcium replacement. Once 
S. Calcium is consistently more than 8.0 mg/dl, the infusion can be 
tapered and stopped. Oral supplementation has to be continued for a 
period of 4-6 weeks. 
  
2.1.5 Permanent hypoparathyroidism and chronic hypocalcemia 
While hypoparathyroidism and the resultant hypocalcemia is 
eminently treatable, permanent hypoparathyroidism is one of the most 
crippling of complications after thyroid surgery. Symptoms and signs of 
hypocalcemia apart, chronic hypocalcemia places the patient at risk of 
significant long-term morbidity, including metastatic calcification of the 
basal ganglia causing seizures and extrapyramidal symptoms [30], 
calcification of the lens capsule, resulting in cataracts [31], reversible 
peripheral neuropathy [32] and hypocalcemic heart failure [33]. The 
clinical features of chronic hypocalcemia are listed in Box 2 [27, 34]. 
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Considering all the above-said factors that influence post-operative 
hypoparathyroidism, the best approach to prevention, especially for 
surgeons, is by means of identification and preservation of the 
parathyroid glands and their blood supply or by autotransplantation of 
one of the parathyroid glands. 
 
BOX 2: CLINICAL FEATURES OF CHRONIC HYPOCALCEMIA 
Neurological signs and symptoms 
Extrapyramidal signs due to calcification of basal ganglia 
Calcification of cerebral cortex or cerebellum 
Parkinsonism 
Ectodermal changes 
Skin: Dry skin, Coarse hair, Brittle nails, Alopecia, Atopic 
eczema, Exfoliative dermatitis, Psoriasis, Impetigo 
herpetiformis 
Teeth: Enamel hypoplasia, Shortened premolar roots, Thickened 
lamina dura, Delayed tooth eruption, Increased dental caries 
Ophthalmologic manifestations 
Subcapsular cataracts 
Cardiac 
Congestive heart failure, Cardiomyopathy 
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2.2 PREVENTION OF POST-OPERATIVE HYPOPARATHYROIDISM:  
       PRESERVATION OF PARATHYROIDS ON THE OPERATING TABLE  
 
Accurate recognition and preservation of normal, vascularised 
parathyroids is dependent on various factors, the foremost of which are 
surgical experience, subjective visual assessment, and a thorough 
knowledge of the gross anatomy of parathyroid glands including blood 
supply. 
 
2.2.1 Anatomy and embryology of the parathyroid glands 
It is common knowledge that there are four parathyroid glands, in 
the neck, with a superior and an inferior gland on each side of the 
midline.  Super-numerary parathyroid glands are seen in upto 13% - 15% 
of the subjects, while 1-3% of the subjects have been reported to have 
fewer than 4 glands [35]. 
These parathyroid glands are embryologically derived from the 
pharyngeal pouches – the inferior glands from the third pharyngeal pouch 
and the superior parathyroids from the fourth pharyngeal pouch.  
As the thymus descends into the lower neck and thorax, the 
parathyroid glands are dragged down and so, come to assume a caudal 
position with respect to those that develop from the fourth pouch. The 
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superior parathyroid glands derived from the fourth pharyngeal pouch, 
develop in the neck. The postero-lateral aspect of the thyroid lobe 
develops from the ventral bud of the fourth pharyngeal pouch on each 
side and thus, the superior parathyroids develop in close proximity to the 
lateral thyroid anlage.  
As a result, the superior parathyroids assume a definitive position 
in close proximity to the postero-lateral border of the thyroid lobe. 
Invariably, the superior glands are enclosed within a thin fascial sheath, a 
so-called capsule, which is continuous with the thyroid capsule. This 
sheath is sometimes vascular. The position of the superior glands is 
relatively constant.   
In a landmark study on parathyroid anatomy based on cadaveric 
dissection [35], 80% of the superior parathyroid glands were found near 
the junction of the cricoids and thyroid cartilages, within 1 cm from the 
intersection of the recurrent laryngeal nerve and the inferior thyroid 
artery.  
They are usually found posterior to the upper pole of the thyroid 
lobe. Sometimes, the glands can be more anterior in position, on the 
surface of the gland within the thyroid capsule.  
The inferior parathyroid glands have a longer path of descent when 
compared to the superior glands and so, it follows that the inferior glands 
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are more variable in position. They are not as closely related to the 
thyroid lobe as the superior glands. They are more variable in their 
distribution. Akerstrom, et al. [35] found the glands in close relation to 
the inferior pole of the thyroid lobe in 44% of subjects. In a further 28%, 
the glands were found in relation to the cervical pole of the thymus or 
within the thyro-thymic ligament in the lower neck. Anomalous 
development of the third pouch can result in an abnormally high location 
of the gland, near the carotid bifurcation.   
A diagrammatic representation of the anatomical variations and the 
frequency with which these variations occur in the population is depicted 
in Figures 1 and 2. The superior and the inferior parathyroid glands and 
their relation to the RLN and ITA are as shown in Figure 3. 
The thin fascial sheath overlying the superior as well as the inferior 
parathyroid glands, which is invariably seen, renders them mobile within 
their capsule, unlike nodules of the thyroid itself or perithyroidal fat or 
lymph nodes. This freedom of movement is one of the key points for 
identification of parathyroids on the operating table.       
Intra-thyroidal parathyroids have been described [35]. The fourth 
pharyngeal pouch, which gives rise to the superior parathyroid gland, also 
gives off the lateral thyroid complex, which gives rise to the lateral part 
of the thyroid lobe. So it should follow that the superior parathyroid 
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glands are more likely to be found in an intrathyroidal location, as was 
postulated [36].  
However, another group of researchers [37] reported on a subset of 
intrathyroidal parathyroid tumours among a series of patients who were 
operated. 7 of the 8 tumours reported were considered to be arising from 
the inferior parathyroid glands.  
Overall, the incidence of intrathyroidal parathyroid glands has been 
reported to be ranging between 0.5% and 3% [35, 36, 38, 39]. 
 
2.2.2. Size, shape and colour of the viable, eutopic parathyroids 
Proper identification requires definition of shape, size and colour 
of the glands as well, in addition to the anatomical position. Because a 
significant part of the gland and the cells are made up of lipids, which are 
fluid at body temperature, these glands are soft in consistency and can be 
easily moulded. The shape is dependent upon the anatomical location and 
the state of the adjacent structures. Those glands that are located in loose 
areolar tissue have an oval, tear-drop or a bean-shaped configuration. 
Those that lie in close relation to the thyroid capsule, especially if the 
thyroid is enlarged, appear flattened with sharp edges. Sometimes, the 
glands can appear elongated. Generally, hyper-functioning glands appear 
rounded and spherical. 
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 Although there is a variation in the size of the normal parathyroid 
gland, glands which are upto 6-8mm in the longest dimension are 
physiologically normal. 
 The colour of normal parathyroid glands ranges from yellowish 
brown to reddish brown. Sometimes, they appear pinkish in contrast to 
the surrounding peri-thyroidal fat. The amount of intra-glandular fat, the 
number of oxyphil cells and extent of vascularity are factors which 
influence the colour of the parathyroid glands [40].  
 
2.2.3. Blood supply of parathyroid glands 
Due to their rich vascularity and fine, delicate vessels, inadvertent 
handling of the glands sometimes leads to bruising of the glands, which is 
apparent on the table as a dusky blush within the parathyroid capsule.  
 Meticulous preservation of the anatomy alone without attention to 
preservation of vascularity will anyway result in loss of functionality. 
While it is traditionally believed that most of the glands are supplied by a 
single end-artery, there is a single arterial supply in 80% of parathyroid 
glands, a double arterial supply in 15%, and multiple arteries in 5% [41].  
In general, the parathyroid glands, regardless of whether superior 
or inferior, derive blood supply from the inferior thyroid artery. However, 
the superior thyroid artery perfuses upto 20% of the superior parathyroids 
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and 10% of the inferior parathyroids. Whatever be the origin of the 
parathyroid arteries, these run in the perithyroidal tissue before entering 
the gland. While ligating the thyroid pedicles, it is preferable to avoid 
ligation of the main trunks of the arteries. A third source of blood to these 
glands is via capsular vessels that run between the thyroid and 
parathyroid glands. This is evident during thyroidectomy, when 
dissection in the interglandular plane may result in bleeding.       
 In the event of unavoidable or inadvertent parathyroidectomy, the 
gland which has been separated is autotransplanted into skeletal muscle. 
This is possible due to certain properties of the parathyroid gland that 
render this a viable option. 
 
2.2.4. Floatation test 
In case of inadvertent parathyroidectomy, it is often not possible to 
differentiate the separated parathyroid gland from peri-thyroidal fat. This 
can be facilitated by immersion of the tissue in question in saline. Fat, 
with a relative density less than that of water, will float to the surface. 
The gland, which has a relative density higher than that of water, will 
sink to the bottom. This is a crude indicator of whether the tissue in 
question is a parathyroid gland or not. The definitive test of confirmation 
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would be a histopathological examination, or at least, microscopic 
examination of a frozen section of the tissue. 
 Thus, the various anatomical attributes by which parathyroid 
glands can eh identified on the operation table include the position with 
relation to the thyroid gland and its capsule, relation to the RLN and the 
ITA, size, shape and colour of the glands, Intracapsular mobility, 
bruisability and blood supply of the parathyroid glands. Flotation test will 
enable identification if inadvertent parathyroidectomy occurs. However, 
the definitive method of identification is microscopic examination of a 
frozen section sample of the harvested tissue. 
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2.3 PARATHYROID PHYSIOLOGY, PHARMACOKINETICS AND PTH ASSAYS 
 
 Parathormone is a polypeptide, made up of 84 amino-acid residues, 
secreted by the parathyroid glands. It is synthesized primarily in the chief 
cells as pre-pro-parathormone, a precursor with 115 amino acid residues. 
As a matter of convention, the amino-acid residues in peptides and 
proteins are numbered from the amino-terminal towards the carboxy-
terminal. The native hormone is then metabolized in the liver to amino-
terminal and carboxy-terminal fragments. The amino-terminal fragment, 
involving the first 27 to 34 amino acid residues, is the biologically active 
part of PTH. The other fragments of PTH are generally inactive 
biologically. While assaying the activity of PTH, measurement of 
biologically active PTH species holds more relevance than measurement 
of inert fragments of the hormone.  
While this is the logical approach to assessment of PTH function in 
theory, it is not so in practice, due to certain pharmaco-dynamic processes 
in the metabolism of PTH. The pre-pro-hormone, which has 113 amino-
acid residues, is the product of the human PTH gene, undergoes changes 
within the chief cell, ultimately resulting in cleavage of the 29-residue 
moiety, resulting in the mature, 84-residue PTH molecule. This is then 
concentrated into secretory vesicles and stored for secretion when 
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necessitated. In addition, other intracellular forms of PTH, like some 
metabolites like amino- and carboxy-terminal peptides, are secreted into 
the circulation.  
This process of intracellular metabolism of PTH is regulated by the 
ambient calcium level in blood. When the level of ambient calcium is 
low, the predominant form secreted is the mature, native molecule (PTH 
1-84). When secretion is suppressed by high calcium levels, most of the 
secretion is in the form of fragments. Once in circulation, these molecules 
are metabolized in the liver and other peripheral sites like the kidneys and 
the bones into peptide fragments, which are found in the circulation [44]. 
So it follows that there are several species of PTH in the circulation 
including the intact PTH, amino-terminal (N-terminal), carboxy-terminal 
(C-terminal) and mid-region fragments [42, 43, 45].  
Each of these types of hormone is detectable by immunoassay 
procedures. The intact hormone makes up about 10% - 20% of the 
circulating immuno-reactive PTH. The remainder is a mixture of other 
peptide fragments of the PTH molecule. 
These circulating forms of PTH are ultimately cleared from the 
circulation by glomerular filtration [42]. So, renal function has a 
significant influence on the level of circulating PTH forms and their 
assays in the blood. 
 26 
 
The intact hormone and its N-terminal fragments disappear rapidly from 
the circulation, with half-lives lasting minutes, while the C-terminal and 
mid-region fragments, although biologically inactive, have longer half-
lives of hours [43, 46].  
Peptides, by nature are heat-labile. So it was traditionally believed 
that estimation of PTH, a labile hormone, necessitated freezing of serum 
as early as possible, in order to obtain reliable results. However, it has 
been found that upto 90% of the immuno-reactivity of PTH is retained for 
upto 4 hours at room temperature, unless the patient has pancreatitis, 
which increases protease activity. 
So it should follow that a delay in the separation of serum and 
freezing doesn’t have a major effect on assay. This is true to an extent. 
Nevertheless, blood samples should be processed within a reasonably 
short time to minimize hormone degradation. Some assay procedures 
employ the usage of enzyme inhibitors in collecting tubes, thus 
prolonging the shelf-life of collected blood.  
 There are two general formats for these assays – the older, one 
epitope-site solution assays and the newer, two epitope-site solid phase 
assays. 
 In the solution assay, antiserum containing a known anti-PTH 
antibody is taken, to which two types of sera are added, the one with 
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known amount of radiolabelled PTH and the other with an unknown 
amount of the patient’s PTH. It is based on competition between the 
known, radiolabelled PTH and the unknown test PTH for the antibody 
sites. 
 The two-site assay or the sandwich assay employs two antibodies 
with separate recognition sites on the antigen. These assays are also 
referred to as immunometric assays. The principle had been recognised 
for years, but advent of enhanced production of monoclonal antibodies 
has enhanced the development of these assays and their clinical 
application. In this assay, one of the antibodies is usually attached to a 
solid matrix like beads or micro-titre wells, while the other antibody is 
radiolabelled. The PTH antigen is the filling in this sandwich.  
 The two-site assay has many advantages, including the ability to 
directly measure specific and defined forms of PTH, increased sensitivity 
even with low-affinity antibodies and absence of non-specific protein 
artefacts, which decrease the accuracy of assays using blood [47-49]. 
 Intact PTH assays (iPTH) are sandwich assays in which one of the 
antibodies is directed against the N-terminal, while the other is directed 
against the C-terminal. A synthetic peptide version is used as the PTH 
standard. With these assays, it is possible to estimate the amount of 
mature, 1-84 PTH.   
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2. 4. PARATHYROID AUTO-TRANSPLANTATION 
 
Intact, viable parathyroids are indispensible for normal calcium 
homeostasis, but as is evident, hypoparathyroidism does occur as a 
complication of thyroid surgery. However, the parathyroid glands have 
certain properties, like the ability to survive by imbibition initially and 
later form blood vessels of their own. Thus, they survive, grow and 
function after transplantation, preventing definitive hypoparathyroidism 
and chronic hypocalcemia. 
 
2.4.1. History of parathyroid auto-transplantation 
Parathyroid Auto-transplantation (PTAT) has been reported for 
over a century. While it was reported in animal studies in 1907, the first 
reported parathyroid autotransplant in a human being was performed by 
William Halsted in 1909, to avoid hypoparathyroidism.  
PTAT during thyroid surgery was first reported in 1926, when it 
was performed during partial thyroidectomy by Lahey [50]. The first 
experience of parathyroid autotransplantation after total 
parathyroidectomy was described in 1968 [51]. 
Viability of the auto-transplanted parathyroid was first reported in 
1975. Wells, et al. [52] reported clinical function and normal histology of 
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the grafts in a large series of patients undergoing PTAT during thyroid 
surgery. In the same year, Hickey and Samaan [53] showed that 
autotransplanted parathyroid glands secrete PTH. 
With time, people started acquainting themselves with the 
techniques of parathyroid autotransplantation and cryopreservation. 
Gradually, these methods gained popularity as measures to lower rates of 
hypocalcemia and hypoparathyroidism following total thyroidectomy. 
Then, as details of parathyroid blood supply were better 
understood, measures like avoidance of truncal ligation of the thyroid 
arteries were described and advocated. As this procedure gained 
acceptance, the rates of identification and preservation of the parathyroid 
glands increased. As a result, the rates of parathyroid gland injury and 
necrosis decreased drastically. While this led to a marked reduction in the 
rates of permanent hypoparathyroidism complicating thyroidectomy, the 
incidence of transient hypocalcemia has remained high. 
 
2.4.2 Imbibition 
Immediately after PTAT, the autotransplanted tissue survives by 
means of imbibition. This refers to the process of passive diffusion of 
water, oxygen and nutrients into the cells of the graft from the 
surrounding tissue fluid. The metabolic wastes diffuse out into the 
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surrounding fluid. Grafts can survive by imbibition for upto a week after 
transplant. The key factors which influence survival of the graft by 
imbibition are the degree of perfusion of the graft bed and the size of the 
bits of tissue that are implanted.  There are many reports [56-59] of 
successful PTAT after transplantation of the tissue within the belly of 
skeletal muscle, a tissue which is well-perfused and well-oxygenated.  
The bits of tissue that are grafted should be small enough to 
survive the immediate post-operative period, before neo-vascularization. 
Successful PTAT has been reported with various sizes of the grafts [60-
62]. 
Transplantation of bits of tissue with a volume of 1mm
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(1x1x1mm) ensures optimal survival of the tissue. With time, new blood 
vessels start to develop within the graft by virtue of angiogenesis. 
Various factors influence this process.  
 
2.4.3 Angiogenesis 
It goes without saying that viability and functionality of a 
transplanted organ or bit of tissue is dependent on reestablishment of a 
functional blood supply. In case of transplant of whole organs like the 
kidney or large volume of tissue, like the liver, graft viability and 
function is based on establishment of intact vascular anastomoses.  
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However, in case of parathyroid autotransplantation, procedures 
like vascular or micro-vascular anastomosis are not performed. This is 
mainly because it is not required, thanks to certain properties exclusive to 
the tissue. The ability of the parathyroid tissue to induce angiogenesis has 
been demonstrated in vitro [63] as well as in vivo [64].  
Vascular endothelial growth factor (VEGF) has been shown to 
contribute to the development of the angiogenic phenotype in vitro [65]. 
Angiogenic activity was observed during the first post-operative week in 
athymic mice which were subjected to parathyroid autotransplantation 
[66]. In addition, reinnervation along newly built blood vessels has been 
demonstrated in transplanted parathyroid tissue 1 week post-operatively 
[67].  
In a trans-species study [60], parathyroid tissue that was harvested 
from patients was cut into 2x2x1 mm pieces, which were subsequently 
transplanted into nude mice. Angiogenesis induced by these grafts was 
detectable by light microscopy on the 5
th
 day after the procedure. Newly 
grown microvessels were seen to be originating from host venules. 
Human iPTH was detected in plasma samples of the mice. So it follows 
that the donor microvessels served as pathways for sprouting 
microvessels. 
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Apparently, vascular ingrowths develop in about 10-20 days 
following implantation [68]. Graft function mirrors this process as well 
and is reflected in serum PTH levels taken during this period. 
So various researchers have reported evidence of angiogenesis and 
neovascularization in the parathyroid implants at various times after 
PTAT, as summarized below.     
 
Researcher   Time after PTAT for angiogenesis 
Ander SJ, et al.   During the first post-operative week 
Luts and Sundler  1 week post-operatively.  
Strieth, et al.   5
th
 day after the procedure 
Wells SA Jr, et al.   10-20 days following implantation 
 
2.4.4 Site for transplantation 
A well-perfused, vascular bed, like skeletal muscle belly, is 
necessary for autotransplantation in order for the graft to survive by 
imbibition before new blood vessels are formed by angiogenesis. 
Generally, the preferred sites for transplantation are the musculature of 
the forearm and the sternocleidomastoid muscle [59, 69-71]. 
According to Walker, et al. [72], the need to re-enter the neck to 
excise hyperfunctioning parathyroid tissue is extremely uncommon in 
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case of PTAT during thyroidectomy, when the parathyroids are not 
diseased. So, the advantage of employing the sternocleidomastoid is that 
another incision can be avoided. However, there are various reports of 
PTAT into the belly of the brachioradialis muscle in the forearm [61, 62, 
73]. It is much easier to assess graft function.  
Funahashi, et al. [59] recommend transplantation of the 
parathyroids into the pectoralis major when a lymph node dissection is 
required for malignancy. The advantage of this method is that the 
pectoralis major is directly accessible through the neck incision. During 
neck dissection, when the sternocleidomastoid muscle is taped and freed 
completely, the blood supply to the muscle may be jeopardized, at least 
transiently. This may adversely affect graft viability. 
In a study by Lo, et al., the harvested parathyroid gland was 
minced into fragments of 0.5 mm size [61]. These were inserted into 
multiple pockets in the brachioradialis muscle, following which survival 
and functionality of the grafts was documented. 
There is a report of successful pre-sternal subcutaneous 
autotransplantation of parathyroid glands. In their study, Kinnaert, et al. 
[74] found that the late results, with respect to graft viability, of total 
parathyroidectomy with pre-sternal subcutaneous autotransplantation 
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compared favourably with published data on other forms of surgical 
treatment of renal hyperparathyroidism. 
So, while there are advocates of various sites within the body for 
implantation of harvested parathyroids, they all concur on the fact that 
belly of the skeletal muscle is a suitable site for PTAT.  
 
2.4.5 Mode of transplantation 
The key to successful graft survival during the first few days after 
PTAT is imbibition. It follows that the smaller the graft, the more the 
chances of survival by imbibition. Billings and Milroy [73] have reported 
successful transplants in which the harvested parathyroid tissue was 
minced in iced Waymouth’s tissue culture medium. The resulting 
suspension was transplanted into the deltoid and brachioradialis muscles, 
by means of placement into pockets as well as by injection into the 
muscles.  
In another study [62] in patients with chronic renal disease and 
parathyroid hyperplasia, total parathyroidectomy and PTAT was 
performed successfully and graft viability was reported. The gland which 
was to be auto-transplanted was sliced into 30 pieces, each of size 1x1x3 
mm. These bits were implanted into 30 pockets in the brachioradialis 
muscle of the forearm. 
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Testini, et al. [24], in their study on the impact of PTAT during 
thyroidectomy, employed a technique in which the harvested parathyroid 
glands were sliced into 1x2mm pieces. One of them was sent for 
histological confirmation, while the rest of them were immediately 
autotransplanted into an intramuscular pocket in the sternocleidomastoid 
on the side of harvest. The site of transplantation was closed with a non-
absorbable suture to prevent extrusion of the graft. The grafts were 
reported to be functional and viable. 
Wells SA Jr., et al. [75], in their report about long-term follow-up 
after PTAT during thyroidectomy, reported that the harvested parathyroid 
gland was sliced into pieces of size 1x3mm, which were implanted into 
muscle pockets in the sternocleidomastoid muscle. These were found to 
be functioning in the long term. 
Delbridge, et al. [76] conducted a prospective randomized 
controlled trial, to compare the outcomes with respect to the procedure of 
parathyroid autotransplantation. The conventional method of implanting 
bits of parathyroid tissue was compared with a novel method of injecting 
a suspension of finely minced parathyroid tissue into the muscle bulk 
(Milroy technique). Post-operative assessment included clinical 
assessment together with estimation of S. Calcium and intact 
parathormone (iPTH) immediately before the procedure and again on 
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post-op days 1, 14 and 90. In both the groups, the procedure was 
followed by a fall in mean PTH levels, but it was significant in the 
implantation group. By 2 weeks, the calcium and iPTH levels had 
returned to baseline levels. None of the patients developed permanent 
hypoparathyroidism.  
  
2.4.6. Number of parathyroids to be grafted 
Another consideration is the number of parathyroids that can or 
should be autotransplanted during thyroidectomy. It is a matter of general 
consensus that up to two glands can be removed without significantly 
increasing the risk of post-operative transient hypoparathyroidism, 
discounting other factors that influence this outcome.  
A couple of studies have compared parathyroid preservation with 
routine autotransplantation of all visualized glands [77, 78]. In the subset 
of patients who underwent routine autotransplantation, incidence rates of 
permanent hypoparathyroidism were 43% and 21.4%. 
According to Imai, et al. [79], the key to avoid post-op 
hypoparathyroidism after total thyroidectomy with PTAT in patients with 
papillary thyroid carcinoma is to find and transplant more than 3 PTGs. 
Various researchers [4, 80] have demonstrated that the number of 
parathyroids transplanted correlated with incidence of transient 
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hypoparathyroidism and post-operative hypocalcemia. However, there 
was no correlation between the number of glands transplanted and 
permanent hypoparathyroidism [80]. 
The removal of a well-vascularized and otherwise normal 
parathyroid gland is unnecessary. It does not reduce the incidence of 
permanent hypoparathyroidism [4].  
So it follows that autotransplantation should only be performed in 
cases of inadvertent parathyroidectomy or devascularisation of the 
glands. Even if performed prophylactically, there is definitely no case for 
autotransplantation of all visualized parathyroids. 
 
2.4.7. Preservation of harvested tissue during surgery  
In their study, Wells SA, Jr. [75], et al. took care to auto-transplant 
the bits of parathyroid tissue into the graft beds within 120 minutes of 
harvesting, to ensure that the grafts were viable. The parathyroid tissue 
was put into iced saline immediately after harvesting. 
Another effect of preservation of tissue in iced saline is that the 
tissue firms up, probably due to solidification of the fat within the tissue. 
This makes it easier to slice or mince the tissue.  
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So it is advisable to put the gland to be transplanted in iced saline 
immediately after harvesting, until the time of auto-transplantation, which 
is best performed within 120 minutes of harvesting. 
2.4.8. Methods of assessment of graft function 
The overwhelming majority of patients undergoing PTAT have 
hyper-parathyroidism. The surgery involves removal of all of the 
functioning parathyroid tissue from the body followed by PTAT, 
invariably in the sternocleidomastoid muscle. Objective determination of 
graft function by means of PTH assays is possible since the graft is the 
only functioning parathyroid tissue in the body.  
On the other hand, in the case of total thyroidectomy, functioning 
parathyroid tissue is left in the neck. Traditionally, determination of graft 
function has been based on the resolution of clinically significant 
hypocalcemia or on the recovery pattern of parathyroid hormone (PTH) 
level [61]. 
Most authors [74, 81, 82] favour the forearm as the site for 
transplanting parathyroid tissue. Estimation of S. PTH from both the 
antecubital fossae is easily done. Graft function can be easily assessed by 
evaluating the PTH gradient between the two sides. 
Lo CY, et al. [61] have documented graft function in PTAT 
following thyroidectomy. The grafts were implanted in to the 
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brachioradialis. S. PTH was estimated in samples from both the 
antecubital fossae. By the 7
th
 week after PTAT, a significant gradient 
between the test and the control arms was established. It seemed that 
normal parathyroid tissue resumed function 2 to 4 weeks after re-
implantation. 
Significant iPTH gradients can be demonstrated in about 80% of 
the patients after autotransplantation [83]. Pre-dilution of the samples to 
1:10 and 1:100 enabled more accurate measurements of iPTH levels [84]. 
Another method of assessment of graft function, the modified 
Casanova test, was described in the setting of recurrent 
hyperparathyroidism in cases of forearm autotransplantation [85]. 
However, this is not applicable to patients undergoing thyroidectomy 
with normal parathyroid function. 
 
2.4.9. Time of assessment of function 
 Various researchers have studied this aspect of PTAT. According 
to Takagi, et al. [86], the gradient of PTH is usually significant (>1.5) 
within 2 or 3 weeks postoperatively. 
Freidman, et al. [15] reported full recovery of parathyroid function 
by the end of 4
th
 week after autotransplantation during thyroidectomy, at 
 40 
 
which point a two-fold increase in mean PTH levels was observed. After 
a further 4 weeks, mean PTH levels had increased by 3-fold.  
According to reports from Korea and Turkey [61, 87], the 
transplanted glands achieve normal function only after 3 to 14 weeks. In 
another study from Greece [62], the transplanted parathyroid tissue 
started functioning after 5.2 months on average (range, 1.7-6.1 months). 
 
2.4.10. Test : Control Ratio 
In humans, a gradient of 1.5 or greater in PTH measurement 
between grafted (test) and non-grafted (control) arms has been generally 
accepted as proof of graft function [64, 75]. 
In their study of long-term parathyroid function following total 
parathyroidectomy with PTAT, Imai, et al. [88], found that the average 
value of iPTH was 36.1 pg/ml in the systemic circulation and 908 pg/ml 
near the transplantation site, giving a ratio of 25.2.  
In the setting of total parathyroidectomy with PTAT, a test-to-
control PTH ratio of 2.0 was found to be helpful in assessing viability and 
function of parathyroid tissue in the forearm [89].  
There have been reports doubting the usefulness of test-to-control 
arm ratio with respect to serum PTH [90]. A hormone gradient between 
the test and control arms may be disguised by high levels of 
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parathormone in the systemic circulation [91]. However, in eucalcemic 
and euparathyroid patients, this ratio is more reliable since the systemic 
levels of PTH are within the normal range [92]. 
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Consecutive patients who underwent total thyroidectomy in the 
Department of Endocrine Surgery, Madras Medical College were 
included in the study. 
 
Pre-operative tests and preparation: 
The thyroid status, parathyroid status and renal function were 
assessed pre-operatively. Those who had hyperthyroidism or 
hypothyroidism were adequately treated with pharmacotherapy (anti-
thyroid drugs or replacement with levo-thyroxine) for a minimum period 
of six weeks. Decision to proceed with surgery was made after 
confirmation of clinical and biochemical euthyroidism. 
 
Exclusion criteria: 
Patients with renal insufficiency and hyperparathyroidism were 
excluded. If the whole of the thyroid gland was not removed (hemi-
thyroidectomy), or if the thyroid gland was not eutopic (ectopic thyroid, 
thyroid hemi-agenesis) such patients were excluded from this study.  
 
Operative procedure: 
Informed consent was obtained after the requisite pre-operative 
preparation and the patients were then posted for surgery. The operative 
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procedure was standardized and was followed by all the surgeons who 
operated on the patients. 
A low collar crease incision was employed and sub-platysmal flaps 
were raised. The sternocleidomastoid muscles on either side were 
reflected to expose the carotid sheath. Neck dissections, if deemed 
necessary, were performed after exposure of the carotid sheath and deep 
cervical lymph nodes. The investing layer of the deep cervical fascia was 
divided in the midline. The sterno-hyoid muscles were retracted laterally 
and the sterno-thyroid muscles were divided near the cranial attachment. 
The number, position, colour, shape and vascularity of parathyroids were 
recorded. If three or more parathyroid glands with normal morphology 
and intact blood supply were seen, one of them was harvested and placed 
in 2 ml of ice-cold saline. The thyroid was removed after identification 
and preservation of the RLN and the remaining parathyroids. 
 
Graft processing:  
A small part of the harvested parathyroid gland was set aside and 
sent for histological confirmation. The remaining gland was finely 
minced to particles of size 1mm
3
 or smaller, as shown in Figure (4). 
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Graft bed preparation and graft implantation:  
The skin overlying the belly of the brachioradialis, in the proximal 
part of the ventero-lateral aspect of the forearm was incised. The 
brachioradialis was exposed (Figure 5). Excessive bleeding, if any, was 
controlled by digital pressure. Care was taken to avoid diathermy over the 
muscle belly. The parathyroid-saline suspension was then injected into 
the graft bed through a wide bore (14 guage) needle (Figure 6). The 
wound was closed with non-absorbable sutures after ensuring that there 
was no extrusion of the graft suspension.  
Care was taken to perform the autotransplantation within 120 
minutes of harvesting the parathyroid gland. 
 
Post-operative monitoring:  
Features of RLN palsy (aspiration, change of voice, hoarseness, 
vocal cord palsy on video-laryngoscopy), if present were noted. If and 
when clinically overt hypocalcemia presented, (muscle weakness, 
perioral and acral paresthesias, Chvostek’s sign, Trousseau’s sign, post-
op S. Calcium) the above-said findings were noted and S. Calcium 
estimated. In asymptomatic patients, the S. Calcium was estimated on the 
third post-operative day. Biochemical hypocalcemia (S. Ca < 8.5 mg/dl), 
if present, was recorded.  
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Severity of hypocalcemia was graded according to the clinical 
features and post-operative level of S. Calcium as given below. 
 
Grading of severity of hypocalcemia: 
Chvostek’s sign: 
Chvostek’s  I – Twitches over the angle of the mouth, the nasal ala, the  
     nasolabial fold and the forehead  
Chvostek’s II – Twitches over the angle of the mouth, the nasal ala and  
   the nasolabial fold 
Chvostek’s III – Twitches over the angle of the mouth alone. 
Trousseau’s sign: 
  Trousseau’s I – Spasm between 1-2 minutes after vaso-occlusion 
  Trousseau’s II – Spasm between 30-60 secs after vaso-occlusion 
  Trousseau’s III – Spasm within 30 secs of vaso-occlusion 
S. Calcium: 
  S. Ca 8.5 mg/dl or above – Eucalcemia 
  S. Ca b/w 8.0 and 8.4 mg/dl – Mild hypocalcemia 
  S. Ca b/w 7.5 and 7.9 mg/dl – Moderate hypocalcemia 
  S. Ca 7.5 mg/dl or below – Severe hypocalcemia 
  S.Ca 6.0 mg/dl or below – Life-threatening hypocalcemia 
 
 
 
 46 
 
Management of hypocalcemia: 
Patients with moderate or severe hypocalcemia post-operative 
hypocalcemia and those with positive Trousseau’s sign were treated with 
intravenous infusion of 10% Calcium gluconate. Simultaneous oral 
supplementation with calcium and 1,25-dihydroxycholecalciferol (1,25-
DHCC) was started. Clinical features including symptoms of 
hypocalcemia, Trousseau’s sign and Chvostek’s sign were monitored 
once in every 6 hrs. Infusion was tapered and terminated after 
confirmation of stabilization of S. Calcium (8.0 mg/dl or more) and 
stabilization of Trousseau’s sign (two consecutive negative responses). 
Those patients with mild hypocalcemia were treated with oral 
supplements as above. The patients were discharged when deemed fit.  
 
Assessment of graft function: 
After a minimum of 90 days following surgery, the patients were 
reviewed. Simultaneous bilateral cubital vein sampling was done and S. 
PTH was estimated in the samples. The graft was deemed viable if the 
test-to-control S. PTH ratio was at least 1.5. All those patients in whom 
the ratio was less than 1.5 were reviewed 6 months after the procedure. 
Blood samples from the test and control arms were taken again and levels 
of PTH were estimated. If the test-to-control ratio was less than 1.5 after 
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6 months, the graft was deemed nonfunctional. Findings were noted, 
tabulated and analyzed. 
 
Statistical Analysis 
After tabulating, the data were analyzed with regards to graft 
function after six months. Graft function was correlated with thyroid 
pathology, presence of thyroiditis, location of the harvested gland, type of 
procedure performed and the cold-ischemia time of the graft.  
 Analysis was performed using the Chi-squared test with Pearson’s 
correlation. Multivariate analysis was performed with the help of logistic 
regression.  
 Statistical analysis was conducted with the help of the SPSS 
software (version 17.0).   
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This study was conducted over a period of 18 months from June 2011 to 
December 2012.  
Out of the 57 patients who were initially included in the study, 4 
parathyroids were identified in 45 patients, while 3 parathyroids were 
identified in a further 6. In the remaining 6 patients, only two glands were 
identified and so, harvesting and autotransplantation was abandoned. Out 
of the 51 patients in whom parathyroid autotransplantation was 
performed, three were lost to follow-up. A total of 48 patients who were 
followed-up with post-operative PTH estimation were included in the 
final analysis. 
 
Demographics 
The mean age of the patients included in this study was 41.1 yrs ± 
13.7. The youngest patient was 17 yrs old, while the oldest patient 
included in this study was 75 yrs old. Of the 48 patients who were 
included in this study, 42 (87.5%) were women and 6 (12.5%) were men 
(Figure 4). 
 
Thyroid status 
As regards to thyroid status, the majority of patients (26 of 48, 
54.2%) were euthyroid, while 9 of them (18.7%) were hyperthyroid at 
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diagnosis and the remaining 13 (27.1%) were hypothyroid at diagnosis. 
Of the 9 patients who were hyperthyroid, 7 of them had benign thyroid 
disease and 2 of them had papillary thyroid carcinoma.  
 
Pathology of the thyroid disease 
With respect to thyroid pathology, the majority of them (28 out of 
48, 58.3 %) had non-toxic nodular colloid goitre. A further 7 of them 
(14.6%) had diffuse goitre. 6 patients (12.5%) had toxic multinodular 
goitre and the other 7 patients (14.6%) had thyroid malignancy [6 patients 
with papillary thyroid carcinoma (PTC) and one patient with medullary 
thyroid carcinoma]. As already mentioned, two of the patients with PTC 
were hyperthyroid at the time of diagnosis.  
In 17 out of 48 patients (35.4%), chronic thyroiditis was evident in 
the final histology, either as the predominant feature or as a co-existing 
feature with the dominant histology. 
 
Type of procedure performed  
Total thyroidectomy (TT) was performed in 41 patients (85.4%). 
Five patients (10.4%) underwent total thyroidectomy with central lymph 
node dissection (CLND). MRND was performed in addition to TT and 
CCLND in two patients (4.2%). 
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Location of the harvested gland and graft bed  
The harvesting of the graft was heterogeneous, with right inferior 
parathyroid gland harvested in 33.3% (n=16), followed by the left inferior 
gland in 27.1%(n=13), the left superior parathyroid in 25%(n=12) and the 
right superior parathyroid in 14.6%(n=7) of the patients.  
The graft was implanted in the right forearm in 23 out of the 48 
patients (47.9%) and in the left forearm in the rest of the 25 patients 
(52.1%). 
 
Functionality of graft 
Overall, of the 48 patients who were included in this study, the 
autotransplanted parathyroid was found functioning, as evidenced by a 
test-to-control ratio of 1.5 or above, in 35 patients (72.9%). In the 
remaining 13 patients (28.1%), the graft was deemed non-functional after 
6 months of autotransplantation. The PTH values and the test-to-control 
ratios  were as shown in Figures 7 and 8. 
Among the 35 patients who had functioning grafts after 180 days, 
the function was established after 90 days in 29 of them. In the remaining 
6 patients, a test-to-control ratio of 1.5 or more was seen by the 180
th
 day 
after autotransplantation.   
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When graft functionality and viability was correlated with 
pathological diagnosis, presence of thyroiditis, site of the gland 
harvested, procedure performed and cold ischemia time, the findings 
were as described under.  
With respect to pathological diagnosis (Table 1), the rate of graft 
viability and functionality was 75% in patients with non-toxic, nodular 
colloid goitre. In patients with diffuse goitre, toxic multinodular goitre 
and malignancy, it was 28.6%, 83.3% and 100% respectively. This 
difference was found to be statistically significant (p = 0.04) on 
univariate analysis. However, on multivariate analysis, this difference 
was not found to be significant (p = 0.11).   
Table 1: Correlation of graft viability and function with histopathological 
diagnosis including thyroiditis 
Pathology Functional 
grafts, n (%) 
Nonfunctional 
grafts, n (%) 
Total 
 
Nontoxic nodular goitre 
 
21 (75.0) 
 
7 (25.0) 
 
28 
 
Diffuse goitre 
 
2 (28.6) 
 
5 (71.2) 
 
7 
 
Toxic MNG 
 
5 (83.3) 
 
1 (16.7) 
 
6 
 
Thyroiditis present 
 
12 (70.6) 
 
5 (29.4) 
 
17 
 
Thyroiditis absent 
 
23 (74.2) 
 
8 (25.8) 
 
31 
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When correlated with thyroiditis (Table 2), the rate of graft 
viability and function at 6 months after autotransplantation was 70.6% 
when thyroiditis was present, as opposed to 74.2% in cases without 
thyroiditis. Although thyroiditis appeared to be inversely related to graft 
viability, this observation was not statistically significant (p = 0.79). 
Of the 29 patients in whom the inferior glands were harvested and 
autotransplanted, they were functioning after 6 months in 19 of them 
(65.5%).In the remaining 19 patients in whom the superior parathyroids 
were harvested, the rate of functionality after 6 months was 84.2 %. 
However, this difference was not statistically significant (p = 0.18, Table 
2). 
Table 2: Correlation of graft viability and site of harvested gland 
Gland harvested Functional 
grafts, n (%) 
Nonfunctional 
grafts, n (%) 
Total 
 
Left Superior 
 
9 (75.0) 
 
3 (25.0) 
 
12 
 
Right Superior 
 
Left Inferior 
 
Right Inferior 
 
7 (100.0) 
 
10 (76.9) 
 
9(56.3) 
 
0 (0.0) 
 
3(23.1) 
 
7(43.7) 
 
19 
 
13 
 
16 
    
 
The rate of graft viability was 69% after total thyroidectomy 
(Figure 8). In patients who underwent total thyroidectomy with lymph 
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node dissection (CLND, MRND or both), the rate of viability was 100%. 
Again, the apparent difference was not statistically significant (p = 0.62) 
The mean time between harvesting and transplantation of the gland 
was 45±6.5 minutes in those who had functioning grafts after 6 months 
(Figure 9). That in the subset of patients with nonviable grafts after 6 
months was 58.5±13.2 minutes (Figure 10). This difference was 
statistically significant (p < 0.001).  
On multivariate analysis, graft survival correlated with cold 
ischemia time of the harvested gland. None of the other factors 
considered had any significant association with graft survival rate.  
 
 
Post-operative sequelae and complications 
Hypocalcemia was seen in 18 out of the total number of 48 patients 
(37.5%). Among them, 8 patients (45.4%) had overt hypocalcemia as 
evidenced by positive symptoms and signs, while the other 10 patients 
(55.4%) had clinically occult hypocalcemia.  
Clinical symptoms of hypocalcemia, including paresthesias and 
cramps were seen in 8 patients (Table 2). The commonest symptom was 
muscle cramp. 6 patients had complaints of paresthesias post-operatively. 
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Signs of hypocalcemia were evident in all the 8 patients, as described in 
Table 3.  
 
Table 3: Post-operative hypocalcemia in the present study 
Patient Acral 
paresthesias 
Perioral 
paresthesias 
Cramps Chvostek’s 
(Grade) 
Trousseau’s 
(Grade) 
1 + - + 2 1 
2 - - + 1 2 
3 + + - 1 2 
4 - + + 2 3 
5 - - - 2 2 
6 - + - 2 1 
7 + - + 3 2 
8 - + - 2 3 
 
 
With regards to the severity, hypocalcemia was mild in 10 patients 
(54.5%), moderate in 6 patients (33.3%) and severe in 2 patients (11.1%), 
as shown in Figure 11. None of these patients had chronic hypocalcemia, 
either clinically overt or biochemically confirmed, 6 months after the 
procedure.  
None of the patients included in the study had symptoms or signs 
of vocal cord palsy, either transient or permanent. 
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The procedure of parathyroid autotransplantation was extensively 
practised by Well SA, Jr., et al., who employed this procedure in the 
setting of hyperparathyroidism. With time, the application of this 
procedure in total thyroidectomy was popularized.  
In case of thyroidectomy, the objective of performing parathyroid 
autotransplantation is prevention of permanent hypoparathyroidism, 
especially in cases of thyroid malignancy involving neck dissection and 
the inherent risk of parathyroid tissue loss. So, the rate of functionality 
and viability of the graft will have a bearing on the rate of permanent 
hypoparathyroidism and chronic hypocalcemia.  
Various studies have been conducted to estimate the parathyroid 
function after parathyroid autotransplantation in thyroid surgery. Largely, 
indirect evidence of graft function has been reported.  
Delbridge, et al. advocates parathyroid autotransplantation as a 
routine during total thyroidectomy. In their study [55], functionality and 
viability of the grafts was evident 3 months after total thyroidectomy and 
parathyroid autotransplantation. While PTH secretion from the grafts was 
not documented, none of the 100 patients included developed permanent 
hypoparathyroidism. In another study [58], normocalcemia was observed 
within 14 weeks of the procedure in all the patients. However, direct 
assessment of the graft function was not reported. Palazzo, et al. [80] 
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reported incidence of temporary hypoparathyroidism ranging between 
9.8% and 31.4% and that of permanent hypoparathyroidism ranging 
between 0% and 0.98% after total thyroidectomy and parathyroid 
autotransplantation. The function of the grafts per se was not reported. In 
their study, Wells SA Jr., et al. [75] performed parathyroid 
autotransplantation after total, subtotal or completion thyroidectomy in 
104 patients. Successful parathyroid autotransplantation was reported in 
103 of these patients. So the rate of functionality was 99% in this study. 
According to Feldman, et al. [105], nearly 53% of patients who 
underwent parathyroid autotransplantation had functioning grafts 3 years 
after the surgery. While the grafts were fully functional in 33% of the 
patients, partial graft function was demonstrated in 20% of the patients. 
The grafts were non functional in about 40% of the patients.  In another 
study by Herrera, et al. [104], graft function was evident 5 years after the 
surgery in over 60% of the patients who underwent parathyroid 
autotransplantation. In another study [106], 95% of the grafts were 
reported to be functional after 6 months. 
In the present study, the overall rate of graft function, as evidenced 
by a test-to-control ratio of 1.5 or more, was 72.9% (35 out of the 48 
patients who were included in the study). 
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While the rate of functionality is consistent with that seen in other 
studies, as mentioned above, the goal of the procedure should be to 
achieve a 100% functionality rate.  
The definitive means of confirmation of parathyroid tissue in the 
harvested sample is by microscopic examination of frozen sections. 
Transplantation after confirmation of parathyroid tissue in the sample will 
ensure that the grafts contain parathyroid tissue.  
Frozen section examination of the harvested sample was not 
performed in the present study. 
Wells SA Jr., et al. has recommended that the graft be transplanted 
within 120 minutes of harvest [75]. In this study, when cold ischemia 
time duration of the graft was correlated with functionality, a significant 
difference was observed in the mean cold ischemia time between the 
viable and the non-viable subsets of patients. Although all grafts were 
transplanted within 120 minutes of harvest, the harvested bits were stored 
in sterilized iced saline. However, it was discovered that by placing the 
harvested glands in iced saline, the grafts were rendered firmer in 
consistency and so, mincing was easier.   
According to Testini, et al., meticulous hemostasis was performed 
in the recipient pocket to prevent collection of a hematoma or a seroma, 
in order to avoid potential destruction of graft [24]. So, it is evident that 
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bleeding in the graft bed, resulting in a hematoma or a seroma, is one of 
the factors which influence graft survival.   
In the present study, diffuse ooze was noted from the subcutaneous 
and intramuscular planes during dissection at the graft bed in some 
patients. Diathermy was not used to control this in order to preserve the 
viability and perfusion of the graft bed. While it was controlled during 
surgery with digital pressure, it may have led to hematoma or seroma 
formation in some patients.    
Extrusion of the harvested tissue may be another factor which will 
impact the overall functionality rate. In the present study, the likelihood 
of graft extrusion is very minimal as the graft was minced in saline and 
the resultant suspension was injected into the muscle belly. 
The pattern of venous drainage of the forearm is another important 
factor that may influence assessment of graft function. In the present 
study, the grafts were implanted into the brachioradialis muscle and blood 
samples were taken from the subcutaneous veins in the cubital fossa. 
While such veins are invariably present, anatomical variations are 
extremely common. While the graft may be viable and functional in 
reality, the assessment may be faulty due to a misrepresentative sample.  
 Stability of the sample is another important factor. PTH, being a 
peptide hormone, is labile. It is vital to process the sample at the earliest 
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while estimating PTH levels. However, degradation of PTH in vitro can 
be effectively delayed by adding enzyme inhibitors in the tube in which 
samples are drawn. It has been found that samples collected in such tubes 
remain stable for a couple of hours or so.  
In the present study, such tubes with enzyme inhibitors were 
indeed employed. 
Various other factors may influence PTH gradients, leading to 
confounding results, although the patients have viable grafts. PTH 
secretion itself may be intermittent. The iPTH gradient may be influenced 
by the regional specificity of the iPTH assay employed. 
In another study, there was no correlation between the test-to-
control ratio of PTH levels and the level of overall graft function [103]. 
In some patients with partial graft function and PTH levels in the normal 
range, hypocalcemia occurred on cessation of calcium supplementation. 
In another study [104], patients with minimal PTH gradients were 
found to be eucalcemic with sufficient graft function after total 
parathyroidectomy and parathyroid autotransplantation. Some others with 
significant gradients had clinically overt hypoparathyroidism. 
Transient hypoparathyroidism after thyroidectomy with 
parathyroid autotransplantation has been widely reported [93-99]. While 
the protective role of parathyroid autotransplantation in definitive 
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hypoparathyroidism has been generally accepted, the effect on transient 
hypo-parathyroidism is still debated.  
It has been reported that inadvertent parathyroidectomy during 
thyroidectomy does not cause postoperative transient hypocalcemia [100, 
101]. Testini, et al. [24] reported that parathyroid autotransplantation was 
protective against transient hypoparathyroidism. The rates of transient 
hypocalcemia were 0% and 2.5% respectively, in those who underwent 
parathyroid autotransplantation along with total thyroidectomy and in 
those who underwent total thyroidectomy alone. According to Karakas, et 
al. [105], the incidence of transient as well as permanent hypocalcemia 
was significantly less in those who underwent parathyroid 
autotransplantation, when compared with those who did not. 
There may be a transient release of PTH immediately following 
parathyroid autotransplantation. Although the transplanted glands seem to 
start functioning after a minimum of 2 weeks, high levels of PTH in the 
minced tissue have been shown [102]. 
Nevertheless, it is also believed that parathyroid autotransplants are 
unlikely to restore eucalcemia in the immediate postoperative period. 
The rate of permanent hypoparathyroidism is not a product of the number 
of glands transplanted at the time of surgery [80]. 
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In the present study, among the patients who were analyzed, post-
operative hypocalcemia was seen in 18 patients (37.5%). This was not 
significantly different from the rate of post-operative hypocalcemia in 
other studies involving total thyroidectomy alone. In addition, none of the 
patients who were operated had hypocalcemia or hypoparathyroidism 6 
months after the procedure.  
One particular patient who was included in this study merits 
mention due to the unusual pattern of results post-operatively. The patient 
was operated for papillary thyroid carcinoma. Total thyroidectomy with 
central compartment lymph node dissection and parathyroid 
autotransplantation was performed. When the graft function was analyzed 
after 90 days, the graft was found to be viable and functional, with a test-
to-control ratio well above 1.5. However, when a whole body radioiodine 
scan was preformed as part of the post-operative follow-up for PTC, a hot 
spot was evident in near the graft bed. 
In summary, while the rate of functionality of the parathyroid 
grafts after autotransplantation was 72.9%, the grafts in the remaining 
patients might be non-functional according to this study due to the 
following causes – absence of parathyroid tissue in the harvested sample,  
prolonged cold ischemia time, seroma or hematoma formation in the graft 
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bed, misrepresentative samples due to anatomical variations in the pattern 
of venous drainage of the forearm and issues with sample stability.  
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In the present study, the overall rate of functionality of the parathyroid 
grafts after total thyroidectomy and parathyroid autotransplantation was 
72.9%. Six months after autotransplantation into the brachioradialis, 
grafts were functioning in 35 out of 48 patients.  
The rate of functionality after autotransplantation was significantly 
influenced by cold ischemia time of the harvested gland. Transplantation 
immediately after harvesting, before proceeding with further dissection 
and surgery, may yield higher functionality rates.   
Graft survival was not significantly influenced by the other factors 
evaluated, including thyroid pathology or the presence of thyroiditis. 
With regards to the site of the harvested gland, the functionality rate was 
apparently higher when the superior parathyroids were harvested, 
although this difference was not statistically significant.  
In this study, the overall rate of transient post-operative 
hypocalcemia was 37.5%. None of the patients included in this study 
developed permanent post-operative hypoparathyroidism.   
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